WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹7,070 Cr | ₹7,075 Cr | ₹7,670 Cr | ₹7,376 Cr | ₹7,749 Cr |
What is the latest Total Liabilities ratio of WOCKHARDT ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹7,070 Cr |
Mar2023 | ₹7,075 Cr |
Mar2022 | ₹7,670 Cr |
Mar2021 | ₹7,376 Cr |
Mar2020 | ₹7,749 Cr |
How is Total Liabilities of WOCKHARDT Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹7,070 Cr | -0.07 | |
Mar2023 | ₹7,075 Cr | -7.76 | |
Mar2022 | ₹7,670 Cr | 3.99 | |
Mar2021 | ₹7,376 Cr | -4.82 | |
Mar2020 | ₹7,749 Cr | - |
Compare Total Liabilities of peers of WOCKHARDT
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WOCKHARDT | ₹24,620.4 Cr | -8.2% | 13.4% | 232.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,363.0 Cr | -2.8% | -3.6% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹158,396.0 Cr | -2.5% | 1.5% | 59.1% | Stock Analytics | |
CIPLA | ₹117,088.0 Cr | -1.5% | 0.2% | 1.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,458.0 Cr | -1.6% | -9.2% | -4.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹94,002.4 Cr | -7.4% | -5.1% | 9.9% | Stock Analytics |
WOCKHARDT Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WOCKHARDT | -8.2% |
13.4% |
232.7% |
SENSEX | -2.7% |
-0.4% |
6.4% |
You may also like the below Video Courses